Deep Track Capital Reports 7.94% Stake in CorMedix Inc. (CRMD)

Deep Track Capital, LP, along with Deep Track Biotechnology Master Fund, Ltd. and David Kroin, filed a Schedule 13G/A on May 15, 2026, disclosing a significant stake in CorMedix Inc. (CRMD). As of the event date on March 31, 2026, the reporting persons collectively hold 6,274,076 shares of common stock, representing a 7.94% ownership interest in the company. This filing marks an increase from a previous 0% position, as indicated by the supplementary data. The shares are held with shared voting and dispositive power among the reporting entities. David Kroin is identified as a control person for Deep Track Capital, LP. The filing was made under Rule 13d-1(c), certifying that the acquisition was made in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The ownership percentage was calculated based on 79,050,395 common shares outstanding as reported in CorMedix's 10-K filed in March 2026.